Asensus Surgical Inc.

0.2620+0.0005+0.19%Vol 759.07K1Y Perf -43.15%
Oct 4th, 2023 16:00 DELAYED
BID0.2610 ASK0.2698
Open0.2600 Previous Close0.2615
Pre-Market- After-Market0.26
 - -  -0.01 -2.29%
Target Price
2.25 
Analyst Rating
Strong Buy 1.00
Potential %
758.78 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-100/71/71 
Value Ranking
★★★★     55.01
Insiders Value % 3/6/12 mo.
-100/89/89 
Growth Ranking
★★★     50.55
Insiders Shares Cnt. % 3/6/12 mo.
-100/83/83 
Income Ranking
 —    -
Price Range Ratio 52W %
1.25 
Earnings Rating
Market Cap69.14M 
Earnings Date
9th Nov 2023
Alpha-0.03 Standard Deviation0.56
Beta1.62 

Today's Price Range

0.26000.2696

52W Range

0.25041.18

5 Year PE Ratio Range

-1.30-0.3000

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-5.76%
1 Month
-12.67%
3 Months
-43.86%
6 Months
-57.74%
1 Year
-43.15%
3 Years
-24.28%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ASXC0.26200.00050.19
AAPL173.661.26000.73
GOOG136.272.97002.23
MSFT318.965.56501.78
XOM111.50-4.3300-3.74
WFC38.970.30000.78
JNJ155.520.18000.12
FB196.640.99000.51
GE108.851.09001.01
JPM143.350.64000.45
Financial StrengthValueIndustryS&P 500US Markets
9.10
10.50
0.04
0.05
-98.70
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
-53.00
-1 019.40
-832.80
-1 349.00
-
RevenueValueIndustryS&P 500US Markets
4.62M
0.02
-24.29
-0.29
Earnings HistoryEstimateReportedSurprise %
Q02 2023-0.08-0.09-12.50
Q01 2023-0.07-0.09-28.57
Q04 2022-0.07-0.070.00
Q03 2022-0.07-0.070.00
Q02 2022-0.08-0.0712.50
Q01 2022-0.08-0.0712.50
Q04 2021-0.07-0.070.00
Q03 2021-0.06-0.060.00
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date9th Nov 2023
Estimated EPS Next Report-0.07
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume759.07K
Shares Outstanding263.87K
Shares Float259.32M
Trades Count1.38K
Dollar Volume200.48K
Avg. Volume2.88M
Avg. Weekly Volume1.26M
Avg. Monthly Volume4.53M
Avg. Quarterly Volume2.85M

Asensus Surgical Inc. (AMEX: ASXC) stock closed at 0.262 per share at the end of the most recent trading day (a 0.19% change compared to the prior day closing price) with a volume of 759.07K shares and market capitalization of 69.13M. Is a component of indices and it is traded on AMEX exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 138 people. Asensus Surgical Inc. CEO is Anthony C. J. Fernando.

The one-year performance of Asensus Surgical Inc. stock is -43.15%, while year-to-date (YTD) performance is -24.52%. ASXC stock has a five-year performance of %. Its 52-week range is between 0.2504 and 1.18, which gives ASXC stock a 52-week price range ratio of 1.25%

Asensus Surgical Inc. currently has a PE ratio of -1.50, a price-to-book (PB) ratio of 0.98, a price-to-sale (PS) ratio of 23.22, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -49.38%, a ROC of -48.50% and a ROE of -55.15%. The company’s profit margin is -%, its EBITDA margin is -832.80%, and its revenue ttm is $4.62 Million , which makes it $0.02 revenue per share.

Of the last four earnings reports from Asensus Surgical Inc., there were 0 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.07 for the next earnings report. Asensus Surgical Inc.’s next earnings report date is 09th Nov 2023.

The consensus rating of Wall Street analysts for Asensus Surgical Inc. is Strong Buy (1), with a target price of $2.25, which is +758.78% compared to the current price. The earnings rating for Asensus Surgical Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Asensus Surgical Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Asensus Surgical Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 28.02, ATR14 : 0.03, CCI20 : -100.21, Chaikin Money Flow : -0.12, MACD : -0.02, Money Flow Index : 37.25, ROC : -9.83, RSI : 39.90, STOCH (14,3) : 12.39, STOCH RSI : 0.39, UO : 33.20, Williams %R : -87.61), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Asensus Surgical Inc. in the last 12-months were: Andrea Biffi (Buy at a value of $207 557), Anthony C. J. Fernando (Option Excercise at a value of $0), Anthony Fernando (Option Excercise at a value of $0), Rampertab Shameze (Option Excercise at a value of $0), Shameze Rampertab (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Asensus Surgical Inc.

Asensus Surgical Inc is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy, and addresses the current clinical, cognitive, economic shortcomings in surgery. The Senhance Surgical System features as the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. Its segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.

CEO: Anthony C. J. Fernando

Telephone: +1 919 765-8400

Address: 1 TW Alexander Drive, Durham 27703, NC, US

Number of employees: 138

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

58%42%

Bearish Bullish

62%38%

 

News

Stocktwits